| November 29, 2016 | Israeli spinal implant company ApiFix has raised a $5 million Series B investment round, which will be closed by the end of next month. ApiFix is developing a minimally invasive deformity correction system for patients with Adolescent Idiopathic Scoliosis (AIS). Based in Misgav in northern Israel, ApiFix is part of the Trendlines Group. B. Braun Melsungen Aesculap division has invested $2.8 million in the latest financing round.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments